Freebird Partners LP - 31 Mar 2025 SCHEDULE 13G/A Report for Ernexa Therapeutics Inc. Common Stock, par value $0.005 per share (ERNA)

Filing Manager
Freebird Partners LP
Reporting Manager
Freebird Partners LP
Security
Ernexa Therapeutics Inc. Common Stock, par value $0.005 per share
Symbol
ERNA
Shares outstanding
62.7M shares
Disclosed Ownership
6.21M shares
Ownership
9.9%
Form type
SCHEDULE 13G/A
Filing time
14 May 2025, 14:14:23 UTC
Date of event
31 Mar 2025
Previous filing
28 Jan 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Freebird Partners LP 9.9% 6.21M 0 6.21M /s/ Curtis Huff Curtis Huff, Chairman and President
Freebird Investments LLC 9.9% 6.21M 0 6.21M /s/ Curtis Huff Curtis Huff, Chairman and President
Curtis Huff 9.9% 6.21M 0 6.21M /s/ Curtis Huff Curtis Huff